New imaging technique allows doctors to 'see' molecular activity

Sep 24, 2007
New imaging technique allows doctors to 'see' molecular activity
On the left hand side of the brain you can see a red netlike structure showing the accumulation of the new agent on specific molecules within inflamed blood vessels. By contrast, the normal side of the brain shows no such effect. If this can be transferred to human use, diagnosis and treatment could start much earlier. Credit: University of Oxford

A new technique that will enable doctors to ‘see’ things happening at the molecular level using standard imaging techniques has been developed by Oxford scientists. The technique has initially been directed towards multiple sclerosis, but long-term it has the potential to be used for a vast range of health problems. The findings are published by Nature Medicine on Monday 24 September.

Dr Robin Choudhury and colleagues at the University of Oxford have developed a marker that attaches itself to particular molecules involved in inflammation. As a result, these molecules ‘light up’ on MRI scans.

The ‘VCAM-1’ molecule plays a key role in inflammation, which contributes to many diseases, including multiple sclerosis, arthritis, inflammatory bowel disease and atherosclerosis (a hardening and narrowing of the arteries which can lead to heart attack and stroke).

By injecting into the body markers that attach themselves to VCAM-1 molecules, and which are visible under MRI scanning, the researchers were able to see on a scan exactly where the molecules were in operation, and in what quantities. The ultimate goal is to facilitate earlier diagnosis, guide treatment and provide more precise monitoring of disease progression.

The team has developed the technique with a view to using it in multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. In MS the body’s own immune system, through inflammation, attacks the fatty tissue surrounding nerve fibres (myelin), which helps nerves carry signals, leading to a range of problems with vision and movement.

Compared to conventional MRI techniques, the new technique has the potential to reveal disease activity much earlier and, crucially, before tissue destruction has occurred. Earlier intervention with drug treatments guided by this information may alter disease progression.

‘Ordinarily, by the time lesions are visible, damage is already done,’ says Dr Choudhury. ‘Therefore molecular imaging techniques to accelerate diagnosis are urgently needed, and we think that this approach shows great potential.’

The work has been carried out so far in mice, but the researchers are optimistic that the technique could translate to humans.

‘In the last few years our knowledge about the cellular and molecular basis of diseases, including MS, has expanded vastly, but we haven’t yet matched these with accompanying advances in imaging,’ says Dr Choudhury. ‘The new technique helps to address that issue.

‘The ultimate goal of this line of work is to develop tools than can accelerate diagnosis, guide specific therapies and monitor response to treatment. In the paper, we make a case as to how this could be applied to multiple sclerosis, but in fact this is a platform technology that, in theory, could be adapted for diagnosis in other brain diseases, cancer and coronary artery disease.’

The full paper ’In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide’ appears online at www.nature.com/nm/

Source: University of Oxford

Explore further: 3-D printing offers innovative method to deliver medication

add to favorites email to friend print save as pdf

Related Stories

CT scan taken of mummified remains in statue

1 hour ago

(Phys.org) —A CT scan and endoscopy have revealed a master's mummy inside a Buddha statue. These were mummified remains of an ancient Buddhist monk who lived during the 11th or 12th century. Investigations ...

Trial nears in high-profile Silicon Valley sex bias case

5 hours ago

(AP)—A jury was picked Monday to determine whether a venerable Silicon Valley venture capital firm is liable in a sexual discrimination lawsuit or is the victim of a former employee forced out because of ...

Recommended for you

Team finds key to tuberculosis resistance

4 hours ago

The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis ...

Mutation may cause early loss of sperm supply

5 hours ago

Brown University biologists have determined how the loss of a gene in male mice results in the premature exhaustion of their fertility. Their fundamental new insights into the complex process of sperm generation ...

No more bleeding for 'iron overload' patients?

7 hours ago

Hemochromatosis (HH) is the most common genetic disorder in the western world, and yet is barely known. Only in the US 1 in 9 people carry the mutation (although not necessarily the disease).

3-D printing offers innovative method to deliver medication

12 hours ago

3-D printing could become a powerful tool in customizing interventional radiology treatments to individual patient needs, with clinicians having the ability to construct devices to a specific size and shape. That's according ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.